泽纳斯生物制药 ZBIO
$28.26 +$2.33 (+8.99%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $28.26 0.00%
开盘$26.21
昨收$25.93
当日区间$25.83 – $28.44
成交量544.0K
市值$1.92B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例124.9%+7.51 个百分点，较上季度
持仓机构数190+5 ，较上季度
内部人近期交易49次买入 / 0次卖出净买入
空头持仓比例19.24% 占流通股回补天数 18.8 · 截至 15 Oct 2026
卖空成交量占比21.2%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：+$942.0K（8个净流入日，12个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有49.3%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从18.62%升至19.24%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| BlackRock | Mutual Fund | 2026/Q3 | +600,796 | 5.0% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +4,972,315 | 10.1% |
| InnoCare Pharma Limited | Public Company | 2026/Q3 | +2,000,000 | 10.7% |
| Hartford Funds Management Company, LLC | Mutual Fund | 2026/Q3 | +111,439 | 0.2% |
| Zebra Aggregator, LP | Mutual Fund | 2026/Q3 | +3,245,404 | 5.0% |
| Hartford Funds Management Company, LLC | Mutual Fund | 2026/Q3 | +104,327 | 0.2% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +869,662 | 1.9% |
| Bank of America Corporation | Public Company | 2026/Q3 | +842,812 | 1.9% |
| BlackRock | Mutual Fund | 2026/Q3 | +648,677 | 4.1% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +584,177 | 3.2% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +540,094 | 1.3% |
| FMR | Mutual Fund | 2026/Q3 | +424,701 | 14.6% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +226,869 | 1.4% |
| AllianceBernstein | Mutual Fund | 2026/Q3 | +206,067 | 1.7% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +184,708 | 2.5% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 31 Aug 2026 | Christy Oliger | Independent Director | Other Derivative Acquisition | +37,000 | $31.98 | 37,000 |
| 25 Aug 2026 | InnoCare Pharma Limited | Initial Statement of Beneficial | +0 | – | 7,000,000 | |
| 14 Jun 2026 | Leon Moulder | Chairperson & CEO | Other Derivative Acquisition | +500,000 | $18.71 | 500,000 |
| 14 Jun 2026 | Patrick Gerald Enright | Independent Director | Other Derivative Acquisition | +18,500 | $18.71 | 18,500 |
| 14 Jun 2026 | Jason Nunn | Independent Director | Other Derivative Acquisition | +18,500 | $18.71 | 18,500 |
| 14 Jun 2026 | Jennifer Fox | Former Chief Business Officer & CFO | Other Derivative Acquisition | +125,000 | $18.71 | 125,000 |
| 14 Jun 2026 | Patricia L. Allen | Independent Director | Other Derivative Acquisition | +18,500 | $18.71 | 18,500 |
| 14 Jun 2026 | Joseph Farmer | COO, President, Principal Financial Officer & Principal Accounting Officer | Other Derivative Acquisition | +175,000 | $18.71 | 175,000 |
| 14 Jun 2026 | John Orloff | Independent Director | Other Derivative Acquisition | +18,500 | $18.71 | 18,500 |
| 14 Jun 2026 | Hongbo Lu | Independent Director | Other Derivative Acquisition | +18,500 | $18.71 | 18,500 |
| 14 Jun 2026 | James Boylan | Lead Independent Director | Other Derivative Acquisition | +18,500 | $18.71 | 18,500 |
| 14 Jun 2026 | Lisa von Moltke | Head of Research & Development and Chief Medical Officer | Other Derivative Acquisition | +150,000 | $18.71 | 150,000 |
| 17 May 2026 | Leon Moulder | Chairperson & CEO | Open Market Acquisition | +60,000 | $16.88 | 520,083 |
| 28 Apr 2026 | Tellus BioVentures, LLC | Open Market Acquisition | +60,000 | $18.02 | 1,786,039 | |
| 30 Mar 2026 | Hongbo Lu | Independent Director | Open Market Acquisition | +3,768 | $18.63 | 426,736 |
| 30 Mar 2026 | Fairmount Funds Management LLC | Private Acquisition | +150,000 | $20.00 | 2,359,025 | |
| 30 Mar 2026 | Nextbio Capital Management LP | Private Acquisition | +75,000 | $20.00 | 422,968 | |
| 30 Mar 2026 | Tellus BioVentures, LLC | Open Market Acquisition | +54,000 | $19.31 | 1,726,039 | |
| 12 Feb 2026 | Patricia L. Allen | Independent Director | Open Market Acquisition | +19,860 | $26.50 | 19,860 |
| 10 Feb 2026 | Nextbio Capital Management LP | Open Market Acquisition | +25,985 | $22.50 | – |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 12,538,549 | 19.2% | 18.8 |
| 30 Sep 2026 | 11,941,601 | 18.3% | 15.5 |
| 15 Sep 2026 | 11,871,346 | 18.2% | 22.4 |
| 31 Aug 2026 | 11,702,288 | 18.0% | 14.2 |
| 14 Aug 2026 | 11,658,986 | 17.9% | 21.1 |
| 31 Jul 2026 | 11,753,566 | 18.6% | 13.8 |
暂无评论——快来第一个聊聊 ZBIO。
登录后参与讨论。